T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 5.15 NOK 6.85%
Market Cap: 1.8B NOK

Wall Street
Price Targets

TRMED Price Targets Summary
Thor Medical ASA

Wall Street analysts forecast TRMED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRMED is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
5.05 NOK
2% Downside
Average
Price Target
5.1 NOK
1% Downside
Highest
Price Target
5.25 NOK
2% Upside
Thor Medical ASA Competitors:
Price Targets
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
ALKS
Alkermes Plc
57% Upside
BMRN
Biomarin Pharmaceutical Inc
53% Upside
CRSP
CRISPR Therapeutics AG
41% Upside
CANTA
Cantargia AB
96% Upside
LXRX
Lexicon Pharmaceuticals Inc
139% Upside
IDYA
IDEAYA Biosciences Inc
42% Upside
EXEL
Exelixis Inc
1% Downside

Revenue
Forecast

Revenue Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Thor Medical ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRMED's stock price target?
Price Target
5.1 NOK

According to Wall Street analysts, the average 1-year price target for TRMED is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Back to Top